Kelvin P. Lee MD
Kelvin P. Lee
MD
Education and Training:
- Fellowship, Research, University of Michigan, Howard Hughes Medical Institute (1991)
- Fellowship, Medical Oncology, University of Michigan Medical School (1990)
- Residency, Internal Medicine, University of Colorado (1987)
- Internship, University of Colorado (1985)
- MD, Internal Medicine, University of Michigan Medical School (1980)
Employment:
- Professor & Chair, Department of Immunology, Roswell Park Cancer Institute (2006-present)
- Research Professor, Medicine, University at Buffalo, The State University of New York Jacobs School of Medicine & Biomedical Sciences (2006-present)
- Vice Chair, Department of Medicine, Roswell Park Cancer Institute (2006-present)
- Professor, Department of Medicine, University of Miami Medical School Department of Microbiology & Immunology (2005–2006)
- Director, Cell Banking and Purification Core Facility, University of Miami Medical School Sylvester Comprehensive Cancer Center (1999–2006)
- Associate Professor, Department of Microbiology & Immunology, University of Miami Medical School Department of Internal Medicine ( Hematology & Oncology) (1999–2005)
- Associate Professor, Department of Internal Medicine, Uniformed Services University of the Health Sciences (1998–1999)
- Branch Head, National Naval Medical Center, Naval Medical Research Institute (1993–1999)
- Research Scientist, National Naval Medical Center, Naval Medical Research Institute (1992–1999)
Awards and Honors:
- Jacobs Family Chair of Immunology (2007)
- Sylvester Scholar (2004)
- Federal Laboratory Consortium Excellence in Technology Transfer Award (1996)
- American Cancer Society Fellow (1991)
- Housestaff Teaching Award, University of Colorado (1987)
- Class Honors, University of Michigan (1980)
- Class Honors, University of Michigan (1979)
- Branstrom Award, University of Michigan (1978)
- Presidential Scholar Finalist (1977)
- National Merit Scholar (1976)
Research Expertise:
- Dendritic cell biology
- Immunology and biology of multiple myeloma: and normal plasma cells
- Novel therapeutics - hematological malignancies
Grants and Sponsored Research:
- September 2011–August 2016
Research in Infectious Diseases, Microbiology and Immunology for Medical Students. T35 Training grant.
NIH, National Institute of Allergy and Infectious Diseases
Role: Co-Principal Investigator
$177,065 - July 2011–June 2016
Epidemiology of breast cancer subtypes in African American women: A consortium.
NIH
Role: Principal Investigator
$200,000 - June 2011–May 2012
A molecular mechanism of breast cancer mediated suppression of the immune system
Alliance Foundation
Role: Principal Investigator
$50,000
Journal Articles:
- Rozanski CH, Utley A, Carlson LM, Farren MR, Murray M, Russell LM, Nair JR, Yang Z, Brady W, Garrett-Sinha LA, Schoenberger SP, Green JM, Boise LH, Lee KP, Garrett-Sinha L. (2015) CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif. J Immunol (May), 194(10): 4717-4728.
- Brady MT, Miller A, Sait SN, Ford LA, Minderman H, Wang ES, Lee KP, Baumann H, Wetzler M. (2013) Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell function. Leuk Res (Jul), 37(7): 822-828.
- Hong CC, Yao S, McCann SE, Dolnick RY, Wallace PK, Gong Z, Quan L, Lee KP, Evans SS, Repasky EA, Edge SB, Ambrosone CB. (2013) Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers. Breast Cancer Res Treat (Jun), 139(2): 477-488.
Professional Memberships:
- The International Cancer Microenvironment Society
- Alpha Omega Alpha Honorary Society